UK Markets open in 7 hrs

Worldwide Medical Tourism Industry to 2029 - Featuring Canopy Growth, Aurora Cannabis and MedMen Among Others

·6-min read
Company Logo
Company Logo

Dublin, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The "Medical Tourism Market Analysis by Treatment, and by Region - Global Forecast to 2029" report has been added to's offering.

The global medical tourism market size is estimated to be USD 46.96 billion in 2021 and is expected to witness a CAGR of 10.79% during the forecast period.

This is owing to hassle-free and affordable international travel, growing healthcare expenses in developed countries, stringent reimbursement policies in local services, and need of quality services. Factors such as supplementary benefits in other countries, advanced technology, sophisticated devices, efficient practitioners, low cost, and better hospitality coupled with personalized care is also boosting the market growth.

However, visa issues, high commissions and scams by middle men, language barriers, documentation issues, and cumbersome insurance reimbursements are expected to hinder the growth.

By Treatment

Based on treatment, the market is segmented into dental, cosmetic, orthopedic, cardiovascular, fertility, bariatric, ophthalmic, and others. In 2021, the cosmetic segment accounted for a significant revenue share owing to increasing awareness for treatment, change in customer perception for cosmetic surgeries, introduction of advanced technology, and quick procedures coupled with better results. The cardiovascular treatment segment is projected to grow at the highest CAGR during the forecast period due to rising prevalence of cardiovascular disorders.

Regional Insights

In 2021, North America was the largest revenue-grossing region in the global market owing to presence of a well-developed healthcare infrastructure, technological advancements, and rising disposable income. However, Asia Pacific is expected to grow at fastest CAGR during the forecast period. This is due to the low medical expenditure, better hospitality, increasing visa approvals, and availability of highly trained medical practitioners with proven track records.

Thailand, India, China, South Korea, Malaysia, and Singapore are the dominant regions in Asia Pacific due to the availability of advanced healthcare services at low cost in these regions. Competitor Insights Some of the major companies in the market are TMC Fertility (Malaysia), Sunway Medical Centre (India), Mexicali Bariatric Center (Mexico), Hospital San Jose (Mexico), Fortis Healthcare Limited (India), Artemis Hospital (India), Asian Heart Institute (India), Apollo Hospitals Enterprise Ltd. (India), Bangkok Dusit Medical Services (Thailand), and Yanhee International Hospital (Thailand).

Increasing investment in healthcare infrastructure, introduction of new services and healthcare packages, comprehensive insurance availability, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry. This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029.

Key Topics Covered:

1. Research Methodology

2. Introduction: Medical Tourism

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraint
4.3. Market Opportunities
4.4. Market Trends
4.5. Market Challenges

5. Market Environment Analysis
5.1. Porter's 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark

6. COVID-19 Impact Analysis: Medical Tourism Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets

7. Market Analysis by Treatment type
7.1. Cosmetic treatment
7.1.1. Cosmetic treatment Market Forecast, 2021-2029 (USD Million)
7.2. Dental treatment
7.2.1. Dental treatment Market Forecast, 2021-2029 (USD Million)
7.3. Orthopedic treatment
7.3.1. Orthopedic treatmentl Market Forecast, 2021-2029 (USD Million)
7.4. Neurological treatment
7.4.1. Neurological treatment Market Forecast, 2021-2029 (USD Million)
7.5. Cancer treatment
7.5.1. Cancer treatment Market Forecast, 2021-2029 (USD Million)
7.6. Fertility treatment
7.6.1. Fertility treatment Market Forecast, 2021-2029 (USD Million)
7.7. Cardiovascular treatment
7.7.1. Cardiovascular treatment Market Forecast, 2021-2029 (USD Million)
7.8. Other treatment
7.8.1. Other treatment Market Forecast, 2021-2029 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends
8.2. Regional Market: Comparative Analysis

9. North America Medical Tourism Market

10. Europe Medical Tourism Market

11. Asia Pacific Medical Tourism Market

12. Latin America Medical Tourism Market

13. MEA Medical Tourism Market

14. Competitor Analysis
14.1. Market Share Analysis, 2021-2029
14.2. Competitive Mapping
14.3. Key Players Market Place Analysis
14.4. Major Recent Developments

15. Company Profiles
15.1. Canopy Growth Corporation (Canada)
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Aurora Cannabis Inc. (Canada)
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. MedMen (US)
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Terra Tech Corp. (US)
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Aphria Inc. (Canada)
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. VIVO Cannabis Inc. (Canada)
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. The Cronos Group (Canada)
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. The Cronos Group (Canada)
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Medical Marijuana Inc. (US)
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. STENOCARE (Denmark)
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Tikun Olam (Israel)
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Organigram Holdings Inc. (Canada)
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Cresco Labs (US)
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Indiva (Canada)
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Curaleaf Holding Inc. (US)
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Product Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players

16. Conclusion & Recommendations

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900